We enjoyed Wallach and colleagues' analysis of sex based subgroup differences in randomised controlled trials in the Cochrane Library.
1 The authors found little evidence for clinically relevant sex-treatment interactions for outcomes.
Not apparent in their analysis are the social, psychological, and contextual factors that can influence men's and women's participation, engagement, and adherence to health interventions, services, and trial procedures, particularly for programmes to change health related behaviours. For example, men are much less likely than women to take part in trials of weight loss programmes for obesity management. To examine the reasons for this, and to help develop interventions that are more likely to engage men to participate in and continue with weight loss programmes, we undertook a mixed methods systematic review of qualitative and quantitative evidence (including randomised controlled trials) of weight management for men who were obese.
2 This led to new guidance endorsed by Public Health England on weight management for men. 4 We performed a pre-specified analysis of dropouts from trials by sex, where individual trials presented data separately for men and women. This showed that, although men were less likely to participate in weight loss trials, they were more likely to complete the trial than women, with an absolute difference of 11% (95% confidence interval 8% to 14%).
5 Sex, and gender, can affect the way we behave, our motivations, our perceptions of the world around us and ourselves, and our reasons for changing (or not) our behaviours. 
